In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Genetics’ clear

  • Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.

Tags: LungCancer, Genetics

  • Dana-Farber was mentioned in a story about how bureaucracy and outdated rules often block potential breakthroughs, but precision medicine is providing hope.

Tags: BasicResearch, Genomics, Genetics

  • Dr. Katherine Janeway led a study finding some pediatric cancer patients harbor mutations in their tumor or germline that have potential clinical significance, either for diagnosis or treatment.

Tags: ChildhoodCancer, Genomics, Genetics

  • In a new study, Dr. Judy Garber credits actress Angelina Jolie’s battle with breast cancer for increasing public awareness of breast cancer surgery options.

Tags: Genetics, CopingWithCancer

  • Dr. Pasi A. Jänne discusses a new study that demonstrates that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Tags: LungCancer, TargetedTherapy, Genetics

  • Dr. Judy Garber commented on ways genetic testing is playing a role in cancer treatment and prevention.

Tags: Genetics, Immunotherapy

  • Dana-Farber was mentioned as one of the cancer centers taking samples of patient’s tumors to analyze with new molecular diagnostic tests and identify a mutation with the hope of matching it with an effective drug.

Tags: Genomics, Genetics

  • Dr. Judy Garber led a study that sought to determine which breast cancer patient populations should be screened for abnormalities and how best to integrate that information into treatment protocols.

Tags: BreastCancer, Genetics

  • MolecularMD has obtained patent rights to technology—jointly owned by researchers at Dana-Farber and the Broad Institute. MolecularMD said it is developing diagnostic assays for use in clinical trials exploring the efficacy of targeted therapies.

Tags: BasicResearch, TargetedTherapy, Genetics

  • Dr. Ursula Matulonis commented on a study that found women with BRCA-1 mutations can reduce their risk of breast and ovarian cancer if they get their ovaries removed by age 35.

Tags: BreastCancer, OvarianCancer, Genetics

Showing 1-10 of 31 items